Here's a Sign of Health

These growth stocks are no longer an anchor to this market.
Stocks quotes in this article: PEP, PCLN, CMG, PCYC, JNJ, LNKD, Z

Classic growth anyone?

That's what it feels like when I see PepsiCo (PEP) up $1.66, Priceline.com (PCLN) up $17, Pharmacyclics (PCYC) up $21 and Johnson & Johnson's (JNJ) stock going up $2 (partner of Pharmacyclics).

Nice to see Chipotle (CMG) up $5, LinkedIn (LNKD) up $2 despite a downgrade and Zillow (Z) rallying another $2.

These stocks had become the anchor to this market, the millstone, glaringly obvious as "wrong" given the selloff in bonds. This move, so pronounced, is saying two things to me:

  1. These stocks, which usually can't be kept back for that long, are advancing as we approach earnings because they will have good ones.
  2. Interest rates might be done with their run up, even if the employment number is strong.

To me, a strong number is baked into the 3% on the 10-year and you won't see a race to 3.25% That could also be why the bank stocks have stalled. They need rates at 3.25% pretty soon because they are anticipating an even bigger net interest margin than we have right now.

Watch these stocks. It's a sign of health that money's going back into them. There are too many of them out there for the market to rally much further without them.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Stocks

More from Stocks

Buying Momentum SNAPs Under Weight of Recession Worries

James "Rev Shark" DePorre

The Dow held its own, but under the surface it wasn't so pretty as the correction churns on.

An ETF for When You're Over ESG

Mark Abssy

Constrained Capital ESG Orphans ETF bets that ESG trends have put undeserved pressure on fossil fuel, nuclear energy, weapons, alcohol, tobacco, and gaming companies.

Meta Platforms: I'm Looking at the Charts, Not the Headlines

Bruce Kamich

Buyers have been attracted in the $180 area in March, April and now.

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin

Here's why this healthcare stock is a potential port in the storm for investors.

Bettin' a Buck on Devon

Mark Sebastian

Here's where I see Devon Energy going and how to play it.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight